BEIJING, Feb. 8 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies,
Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro
diagnostic ("IVD") company, today announced that it will participate at the
following investor conferences in March 2010:
About China Medical Technologies, Inc.
China Medical Technologies, Inc. is a leading China-based advanced IVD company using Fluorescent in situ Hybridization (FISH) technology, Surface Plasmon Resonance (SPR) technology and Enhanced Chemiluminescence Immunoassay (ECLIA) technology to develop, manufacture and distribute diagnostic products for detecting and monitoring various cancers, diseases and disorders. For more information, please visit http://www.chinameditech.com .
Advertisement
Investor Conference Date Location
Rodman & Renshaw Annual March 7-9, 2010 The Regent Hotel,
China Investment Beijing
Conference
Credit Suisse Asian March 22-26, Conrad Hong Kong
Investment Conference 2010
2010
The Company's Chief Financial Officer, Mr. Sam Tsang, will discuss the
Company's strategies, operations, growth opportunities as well as its
published financial results to date with institutional investors during the
two investor conferences.Advertisement
About China Medical Technologies, Inc.
China Medical Technologies, Inc. is a leading China-based advanced IVD company using Fluorescent in situ Hybridization (FISH) technology, Surface Plasmon Resonance (SPR) technology and Enhanced Chemiluminescence Immunoassay (ECLIA) technology to develop, manufacture and distribute diagnostic products for detecting and monitoring various cancers, diseases and disorders. For more information, please visit http://www.chinameditech.com .
For more information, please contact:
Winnie Yam
Tel: +852-2511-9808
Email: [email protected]
SOURCE China Medical Technologies, Inc.